Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Counterfeit and Falsified Drugs: an Overview].
Taverriti-Fortier C, Pape E, Scala-Bertola J, Tréchot P, Maincent P, Gibaja V, Gambier N. Taverriti-Fortier C, et al. Among authors: gibaja v. Therapie. 2015 Sep-Oct;70(5):455-64. doi: 10.2515/therapie/2015031. Epub 2015 Jun 12. Therapie. 2015. PMID: 26071144 French.
[Surveillance system on drug abuse: Interest of the French national OPPIDUM program of French addictovigilance network].
Frauger E, Pochard L, Boucherie Q, Giocanti A, Chevallier C, Daveluy A, Gibaja V, Caous AS, Eiden C, Authier N, Le Boisselier R, Guerlais M, Jouanjus É, Lepelley M, Pizzoglio V, Pain S, Richard N, Micallef J; le Réseau français d’addictovigilance. Frauger E, et al. Among authors: gibaja v. Therapie. 2017 Sep;72(4):491-501. doi: 10.1016/j.therap.2017.01.010. Epub 2017 Feb 22. Therapie. 2017. PMID: 28343650 French.
[French trends in the misuse of Fentanyl: From 2010 to 2015].
Tournebize J, Gibaja V, Frauger E, Authier N, Seyer D, Perri-Plandé J, Fresse A, Gillet P, Javot L, Kahn JP; et le réseau français d’addictovigilance. Tournebize J, et al. Among authors: gibaja v. Therapie. 2020 Sep-Oct;75(5):491-502. doi: 10.1016/j.therap.2019.11.002. Epub 2019 Nov 25. Therapie. 2020. PMID: 31826806 French.
[Increase of overdose and deaths related to methadone during COVID-19 epidemic in 2020].
Frauger E, Fouilhé N, Lacroix C, Daveluy A, Le Boisselier R, Bertin C, Revol B, Carton L, Chevalier C, Eiden C, Gibaja V, Aquizerate A, Chaouachi L, Bouquet E, Roussin A, Mallaret M, Micallef J. Frauger E, et al. Among authors: gibaja v. Therapie. 2023 Jun 15:S0040-5957(23)00084-7. doi: 10.1016/j.therap.2023.06.004. Online ahead of print. Therapie. 2023. PMID: 37391322 Free PMC article. French.
[The current aspects of the use of ecstasy/MDMA in France].
Spadari M, Batisse A, Guerlais M, Boucher A, Daveluy A, Le Boisselier R, Gibaja V, Eiden C, Lepelley M, Roussin A, Deheul S, Frauger E, Debruyne D. Spadari M, et al. Among authors: gibaja v. Therapie. 2016 Dec;71(6):553-562. doi: 10.1016/j.therap.2016.05.005. Epub 2016 Jun 7. Therapie. 2016. PMID: 27371364 French.
Addictovigilance contribution during COVID-19 epidemic and lockdown in France.
Lapeyre-Mestre M, Boucher A, Daveluy A, Gibaja V, Jouanjus E, Mallaret M, Peyrière H, Micallef J; French Addictovigilance Network. Lapeyre-Mestre M, et al. Among authors: gibaja v. Therapie. 2020 Jul-Aug;75(4):343-354. doi: 10.1016/j.therap.2020.06.006. Epub 2020 Jun 23. Therapie. 2020. PMID: 32660776 Free PMC article. Review.
37 results